Zymeworks Inc (ZYME)
8.55
-0.16
(-1.84%)
USD |
NASDAQ |
Apr 23, 16:00
8.55
0.00 (0.00%)
After-Hours: 20:00
Zymeworks Cash from Operations (TTM): -118.30M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -118.30M |
September 30, 2023 | 195.10M |
June 30, 2023 | 164.76M |
March 31, 2023 | 116.33M |
December 31, 2022 | 144.11M |
September 30, 2022 | -233.76M |
June 30, 2022 | -211.53M |
March 31, 2022 | -207.06M |
December 31, 2021 | -192.45M |
September 30, 2021 | -189.84M |
June 30, 2021 | -155.12M |
March 31, 2021 | -154.72M |
December 31, 2020 | -151.40M |
September 30, 2020 | -139.85M |
June 30, 2020 | -134.68M |
Date | Value |
---|---|
March 31, 2020 | -98.04M |
December 31, 2019 | -81.85M |
September 30, 2019 | 4.606M |
June 30, 2019 | 2.669M |
March 31, 2019 | 20.45M |
December 31, 2018 | 24.18M |
September 30, 2018 | 13.09M |
June 30, 2018 | 13.75M |
March 31, 2018 | -4.655M |
December 31, 2017 | 0.219M |
September 30, 2017 | -47.39M |
June 30, 2017 | -49.64M |
March 31, 2017 | -40.97M |
December 31, 2016 | -35.25M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-233.76M
Minimum
Sep 2022
195.10M
Maximum
Sep 2023
-75.84M
Average
-134.68M
Median
Jun 2020
Cash from Operations (TTM) Benchmarks
Emergent BioSolutions Inc | -206.30M |
MariMed Inc | 7.91M |
Viemed Healthcare Inc | 45.21M |
NovaBay Pharmaceuticals Inc | -4.131M |
Palatin Technologies Inc | -26.54M |